Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended
	Mar. 31, 2013	Apr. 01, 2012
Cash flows from operating activities:
Net loss	$ (11,755,000)	$ (19,577,000)
Add: loss (income) from discontinued operations (net of $0 tax)	2,738,000	(5,189,000)
Loss from continuing operations	(9,017,000)	(24,766,000)
Adjustments to reconcile loss from continuing operations to net cash used in operating activities:
Depreciation and amortization	95,000	22,000
Non-cash interest expense	5,255,000	2,779,000
(Gain) loss from changes in fair value of derivative liability	(4,481,000)	16,470,000
Common stock and warrants issued to pay operating expenses	139,000
Non-cash stock-based compensation	300,000	330,000
(Increase) in accounts receivable	(127,000)
(Increase) in prepaid expenses and other assets	(60,000)	(97,000)
Increase in accounts payable and accrued expenses	504,000	935,000
(Decrease) in Executive Salary Continuation Plan liability	(7,000)	(29,000)
Increase in deferred revenue	67,000
Net cash used in operating activities	(7,332,000)	(4,356,000)
Cash flows from investing activities:
Property and equipment expenditures	(45,000)	(60,000)
Proceeds from sale of Thermal Imaging Business	1,200,000
Net cash paid related to acquisition of Bivio	(569,000)
Net cash provided by (used in) investing activities	586,000	(60,000)
Cash flows from financing activities
Proceeds from issuances of debt	7,380,000
Proceeds from revolving credit line		5,000,000
Debt issuance costs paid		(143,000)
Principal payments of notes payable and settlement agreements	(9,000)	(2,497,000)
Principal payments of capital leases	(8,000)	(6,000)
Net cash provided by financing activities	7,466,000	2,551,000
Cash flows from discontinued operations:
Net cash used in operating activities	(1,965,000)	(1,854,000)
Net cash used in investing activities	(8,000)	8,165,000
Net cash provided by (used) in discontinued operations	(1,973,000)	6,311,000
Effect of foreign currency translation	(163,000)
Net increase (decrease) in cash and cash equivalents	(1,416,000)	4,446,000
Cash and cash equivalents at beginning of period	1,738,000	2,735,000
Cash and cash equivalents at end of period	322,000	7,181,000
Non-cash investing and financing activities:
Non-cash conversion of preferred stock to common stock	60,000	250,000
Conversion of Subordinated Secured Convertible Promissory Notes and accrued interest to common stock	30,000
Non-cash conversion of 2012 Notes to 2013 Notes, including paid in kind interest	5,571,000
Common stock issued to pay accrued interest and board fees	963,000	482,000
Issuance of warrants to acquire Bivio Software assets	85,000
Senior Subordinated Note issued to settle accrued interest	291,000
Issuance of warrants in connection with the Forbearance agreements	721,000
Supplemental cash flow information:
Cash paid for interest	303,000	267,000
Cash paid for income taxes	$ 3,000	$ 3,000